HELIOS-B: A Phase 3, Randomized, Doubleblind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with Cardiomyopathy)
2022-06-29
عنوان الدراسة
HELIOS-B: A Phase 3, Randomized, Doubleblind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with Cardiomyopathy)
داعم الدراسة
Alnylam Pharmaceuticals.
دواء الدراسة
ALN-TTRSC02 (Vutrisiran)
رقم بروتوكول الدراسة
ALN-TTRSC02-003
حالة الدراسة
Ongoing
موقع الدراسة
King Khalid University Hospital (Riyadh)
مرحلة الدراسة
3
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.